Nutrition 21, Inc. (NASDAQ: NXXI) announced new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome?, a patented combination of chromium picolinate and biotin, significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
Januvia (scientific name sitagliptin), a new drug designed to improve blood sugar control in patients with type 2 diabetes, should not be used because the drug?s long-term safety is still unknown, Public Citizen writes in a new June posting on its WorstPills.org Web site.
Researchers in endocrinology and obstetrics and gynecology at Cedars-Sinai Medical Center will make several presentations at the upcoming annual meetings of two medical organizations ? the Androgen Excess Society (June 1, 2007) and the Endocrine Society (June 2-5, 2007).
Researchers have shown that key chemicals that carry cholesterol and fats in the blood accumulate in people with type 2 diabetes, which may help improve treatment of this disease.
GlaxoSmithKline (GSK) confirms that a letter to the editor summarising additional Avandia cardiovascular safety data from several large-scale clinical trials was published online today in The Lancet.
Why do older people tend to lose muscle mass and grow frail? One important factor identified by medical science is the reduced ability of the elderly to respond to the muscle-building stimulus of the hormone insulin.
A new book launched by the Parliamentary Secretary to the Minister for Health and Ageing, Senator Brett Mason, aims to decipher the meaning of food labels.
A new report released by the Australian Institute of Health and Welfare (AIHW), examines levels of death and disability from a variety of diseases, injuries and health risks to determine the total ‘burden of disease’ in Australia.
Ohio University researchers conduct two-year intervention feasibility study to test the effectiveness of a combination of exercise and talk therapy as a treatment for depression in patients with type 2 diabetes.
The U.S. Food and Drug Administration (FDA) issued a safety alert on Avandia, diabetes drug approved to treat type 2 diabetes. I believe safety alert on Glaxo’s diabetes drug Avandia is a timely action by US FDA health agency, remarked Dr. Anil Singhal.